MarketPeel
Insider Trading Intelligence
Pricing
…
RT

Robert Tjian

NRIX
DIRECTOR · NURIX THERAPEUTICS, INC. · CIK 0001817230
FILING MIX · LIFETIME50%/50%
BUYS
2
SELLS
2
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jul 2020
HOLDINGS NOW
0
AVG SELL PX
—
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Robert Tjian. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
NRIX · 0 shares · as of Jul 28, 2020
031,25062,50093,749124,999SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
FLOW · 2 buys / 2 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
NRIX
NURIX THERAPEUTICS, INC.
SALE
50,000——0Jul 28, 2020Jul 29, 2020 ↗
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
50,000——124,999Jul 28, 2020Jul 29, 2020 ↗
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
41,666——74,999Jul 28, 2020Jul 29, 2020 ↗
NRIX
NURIX THERAPEUTICS, INC.
SALE
41,666——0Jul 28, 2020Jul 29, 2020 ↗
Other insiders · NRIX
Loading peer insiders…
About this filer
CIK 0001817230
ROLE
Director
PRIMARY
NRIX
COMPANIES
1
ACTIVE SINCE
Jul 2020
MARKETPEEL · /INSIDER/0001817230DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback